Profile of Blood Pressure, Uterine Contractions, and Fetal Heart Rate Of Gravida with Neuroprotectant Therapy at RSUD Dr. Saiful Anwar
Profile of Blood Pressure, FHR, and Uterine Contractions Of Gravid Women with MgSO4 Neuroprotectant Therapy at HCU Ranu Grati RSUD Dr. Saiful Anwar
DOI:
https://doi.org/10.11594/jk-risk.04.3.3Keywords:
NEUROPROTEKTAN, MgSO4Abstract
Background: Neuroprotectants are substances used to protect the nerves of fetuses at risk of premature birth. Administration of MgSO4 as a neuroprotectant is one of the interventions given to gravida at risk of premature birth at Dr. Saiful Anwar Hospital. MgSO4 has a vasodilator side effect that is thought to cause a hypotensive effect. Magnesium also has a relaxing effect on smooth muscles which is expected to have the effect of reducing uterine contractions. It is not yet known how MgSO4 affects fetal heart rate. Aim: This study aims to determine the condition of maternal blood pressure, maternal uterine contractions, and fetal heart rate when MgSO4 is administered at the Ranu Grati HCU, Dr. Saiful Anwar Hospital in 2022-2023. Method: Retrospective descriptive study using secondary data. Data were collected from medical records from January 2022 to December 2023 at the Ranu Grati HCU, Dr. Saiful Anwar Hospital. The subjects in this study were all clinical data of gravida patients who received MgSO4 therapy as a neuroprotectant. Preeclampsia gravida patients who received MgSO4 were included in the exclusion criteria. Results: The study or 36 respondents, showed the average of systolic blood pressure of respondents decreasing up to 6,469 mmHg at 16thof MgSO4 admisnistration, then at the 24th hour of administration, systolic blood pressure increased by 0.3 mmHg. The average of diastolic blood pressure decreased by 4.4723 mmHg which occurred from the 0th hour to the 24th hour. Fetal Heart Rate showed a decrease in DJJ frequency of an average of 5,2x/minute. In uterine contractions, 91.7% of patients did not experience uterine contractions during neuroprotectant administration. Conclusion: Neuroprotectant administration has an insignificant effect on reducing blood pressure, fetal heart rate, and maternal uterine contractions. Keywords: Neuroprotectant; MgSO4
Downloads
References
Anna G. Euser., Marilyn J. Cipolla. Magnesium sulfate for the treatment of eclampsia: a brief review. April 2009;40(4):1169-75. doi: 10.1161/STROKEAHA.108.527788.
Bain ES, Middleton PF, Yelland LN, Ashwood PJ, Crowther CA. Efek samping maternal dengan laju infus magnesium sulfat antenatal yang berbeda untuk perlindungan saraf janin prematur: uji coba acak IRIS. BJOG. 2014; 121 :595–603.
Bouet, P. E., Brun, S., Madar, H., Baisson, A. L., Courtay, V., Gascoin-Lachambre, G., Lasocki, S., & Sentilhes, L. (2015). Implementation of an antenatal magnesium sulfate protocol for fetal neuroprotection in preterm infants. Scientific Reports, 5(August), 1–8. https://doi.org/10.1038/srep14732
C. Abad, F.R. Vargas, T. Zoltan, T. Proverbio, S. Piñero, F. Proverbio, R. Marín. (2015). Magnesium sulfate affords protection against oxidative damage during severe preeclampsia. Volume 36, Issue 2, February 2015, Pages 179-185.
Cassandra R. Duffy, MD, MPH, Anthony O. Odibo, MD, MSCE, Kimberly A. Roehl, MPH, George A. Macones, MD, MSCE, and Alison G. Cahill, MD, MSCI. (2012). Effect of Magnesium Sulfate on Fetal Heart Rate Patterns in the Second Stage of Labor. (Obstet Gynecol 2012;119:1129–36) DOI: 10.1097/AOG.0b013e318257181e
Crowther, C. A., Brown, J., Mckinlay, C. J. D., & Middleton, P. (2014). Magnesium sulphate for preventing preterm birth in threatened preterm labour. Cochrane Database of Systematic Reviews, 2014(8). https://doi.org/10.1002/14651858.CD001060.pub2
Edwards, J. M., Edwards, L. E., Swamy, G. K., & Grotegut, C. A. (2018). Magnesium sulfate for neuroprotection in the setting of chorioamnionitis. Journal of Maternal-Fetal and Neonatal Medicine, 31(9), 1156–1160. https://doi.org/10.1080/14767058.2017.1311312
Haram, K., Mortensen, J. H. S., & Morrison, J. C. (2015). Tocolysis for acute preterm labor: Does anything work. Journal of Maternal-Fetal and Neonatal Medicine, 28(4), 371–378. https://doi.org/10.3109/14767058.2014.918095
Jeswani, R., Patil, Y., & Patil, S. (2021). Intravenous magnesium sulfate and isoxsuprine for arrest of preterm labor: A comparative study. Journal of Natural Science, Biology and Medicine | Published by Wolters Kluwer - Medknow, 9(May), 14–18. https://doi.org/10.4103/jnsbm.JNSBM
Jung, E. J., Byun, J. M., Kim, Y. N., Lee, K. B., Sung, M. S., Kim, K. T., Shin, J. B., & Jeong, D. H. (2018). Antenatal magnesium sulfate for both tocolysis and fetal neuroprotection in premature rupture of the membranes before 32 weeks’ gestation. Journal of Maternal-Fetal and Neonatal Medicine, 31(11), 1431–1441. https://doi.org/10.1080/14767058.2017.1317743
Kass, L., Weekes, J., & Carpenter, L. (2012). Effect of magnesium supplementation on blood pressure: A meta-analysis. European Journal of Clinical Nutrition, 66(4), 411–418. https://doi.org/10.1038/ejcn.2012.4
Kawagoe, Y., Sameshima, H., Ikenoue, T., Yasuhi, I., & Kawarabayashi, T. (2011). Magnesium sulfate as a second-line tocolytic agent for preterm labor: a randomized controlled trial in Kyushu Island. Journal of Pregnancy, 2011, 965060. https://doi.org/10.1155/2011/965060
Matondang, H. A., Sulaeman Effendi, J., Handono, B., Kurniadi, A., Obstetri, D., Ginekologi, D., Kedokteran, F., Padjadjaran, U., Sakit, R., Sadikin, H., Korespondensi, B., Heri, :, & Matondang, A. (2018). Penggunaan Magnesium Sulfat untuk Menurunkan Angka Kejadian Cerebral Palsy pada Bayi Prematur.
Nensi, A., De Silva, D. A., von Dadelszen, P., Sawchuck, D., Synnes, A. R., Crane, J., Magee, L. A., Ansermino, M., Brant, R., Joseph, K. S., Liston, R., Allen, V., Audibert, F., Bujold, E., Piedboeuf, B., Walker, M., Whittle, W., & Young, C. (2014). Effect of Magnesium Sulphate on Fetal Heart Rate Parameters: A Systematic Review. Journal of Obstetrics and Gynaecology Canada, 36(12), 1055–1064. https://doi.org/10.1016/S1701-2163(15)30382-0
Oliveira CA, Moreira De Sa RA, Zamprogno KV, Gutierrez Da Matta F, Do Vale Araújo F. (2017). Magnesium sulfate and ophthalmic artery Doppler velocimetry in patients with severe preeclampsia: A case series. J Med Case Rep. vol. 11. no. 1. hh. 1-6
Singh R et al. (2016). Assessment of the effect of injection magnesium sulphate on fetal heart rate pattern in patients of eclampsia and preeclampsia. Int J Reprod Contracept Obstet Gynecol. Nov;5(11):3667-3670
Sugimoto, H., LeBleu, V., Bosukonda, D. et al. Activin-like kinase 3 is important for kidney regeneration and reversal of fibrosis. Nat Med 18, 396–404 (2012). https://doi.org/10.1038/nm.2629
Sujardi LM. (2015). Kajian Farmakokinetika dan Dampak Farmakodinamika Magnesium Sulfat pada Penderita Preeklamsia Tinjauan Pengaruh Perbedaan Rute Pemberian MgSO4 Terhadap Perubahan Tekanan Darah Serta Kadar NO dan VEGF Serum. Yogyakarta: Universitas Gajah Mada.
Suvarna V N Malapaka, Priya K Ballal. 2011. Low-dose magnesium sulfate versus Pritchard regimen for the treatment of eclampsia imminent eclampsia. Int J Gynaecol Obstetri 2011 Oct;115(1):70-2.doi: 10.1016/j.ijgo.2011.05.013. Epub 2011 Jul 27.
WHO. (2014). WHO RECOMMENDATIONS FOR PREVENTION AND TREATMENT OF PRE- ECLAMPSIA AND ECLAMPSIA Implications and Actions.
WHO. (2023). Born too soon: decade of action on preterm birth..
Zhang, X., Li, Y., Del Gobbo, L. C., Rosanoff, A., Wang, J., Zhang, W., & Song, Y. (2016). Effects of Magnesium Supplementation on Blood Pressure: A Meta-Analysis of Randomized Double-Blind Placebo-Controlled Trials. Hypertension, 68(2), 324–333. https://doi.org/10.1161/HYPERTENSIONAHA.116.07664/SUPPL_
FILE/HYP_HYPE201607664-T_SUPP1.PDF
Downloads
Published
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal the right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors can enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) before and during the submission process, as it can lead to productive exchanges and earlier and greater citation of published work (See The Effect of Open Access).










